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The Epstein–Barr virus (EBV), a B-lymphotropic human
herpesvirus that infects the majority of the world’s adult popula-
tion, has been linked to a number of human malignancies,
including Burkitt’s lymphoma, nasopharyngeal carcinoma and,
more recently, Hodgkin’s disease (HD). The observation that
persons with a history of infectious mononucleosis have a two- to
threefold increased risk of HD (Gutensohn and Cole, 1980) and
the detection of elevated levels of antibodies to viral antigens in
HD patients prior to, or at the time of, diagnosis (Mueller et al,
1989; Levine et al, 1994; Alexander et al, 1995) provided the first
evidence to suggest a causal role for EBV in HD.
Direct evidence for the association was provided by the local-
ization of EBV DNA to the malignant Hodgkin and Reed–
Sternberg (HRS) cells of HD (Weiss et al, 1987). Subsequently, the
presence of latent EBV infection of tumour cells in HD was
confirmed by in situ hybridization and immunohistochemical
assays that targeted the highly abundant Epstein–Barr virus early
RNAs (EBERs) and the latent membrane protein-1 (LMP1)
(Anagnostopoulos et al, 1989; Wu et al, 1990; Pallesen et al, 1991;
Murray et al, 1992). However, the frequency of EBV-positivity in
HD tumours was found to be dependent upon several factors
including age, sex and country of residence. EBV is more
commonly associated with the mixed cellularity subtype and less
frequently with the other forms of this disease (Pallesen et al,
1991; Murray et al, 1992; Jarrett et al, 1996; Glaser et al, 1997).
In addition, Hodgkin’s disease at older ages (> 55 years) and in
children, especially those under 10 years, is more likely to be
EBV-associated than is HD in young adults (Jarrett et al, 1991,
1996; Glaser et al, 1997; Armstrong et al, 1998a). The infrequent
association of EBV with HD in young adults has prompted the
suggestion that a second virus may be involved, although there is
little evidence to support this at present (Armstrong et al, 1998b).
EBV-positive HD tumours also appear to be less common in
developed populations, with percentages of between 30 and 50%
for North American and European cases (Wu et al, 1990; Weiss
et al, 1991; Herbst et al, 1992; Hummel et al, 1992), 57% for HD
in China (Zhou et al, 1993), but with much higher rates (up to
100%) in underdeveloped countries such as Peru (Chang et al,
1993) and Kenya (Leoncini et al, 1996; Weinreb et al, 1996a,
1996b). In the present study, we have investigated whether in the
UK, the frequency of EBV infection in Hodgkin’s tumours is
higher in underprivileged populations.
MATERIALS AND METHODS
Patients
Paraffin wax-embedded tissue blocks from patients with histologi-
cally confirmed Hodgkin’s disease diagnosed between 1981 and
1997 were retrieved from the files of a number of hospitals in the
West Midlands Region, including Russells Hall Hospital, Dudley;
Good Hope Hospital, Sutton Coldfield; New Cross Hospital,
Wolverhampton; and the Manor Hospital, Walsall. There were no
specific exclusion criteria and children as well as adults were
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included. When patients from the present study were grouped into
age ranges (0–14, 15–34, 35–54, > 55 years) and incidence rates
compared to those in the West Midlands region there was found to
be no significant difference, thus indicating that our patient group
was representative of the West Midlands as a whole. Date of diag-
nosis and date of birth, sex and postcode data were collected
anonymously for each patient.
Histological review
Haematoxylin and eosin-stained slides from all tissue blocks were
prepared and reclassified according to the REAL classification
system (Harris et al, 1994) by a single pathologist (JC). Four-
micrometer paraffin-sections were prepared, deparaffinized and
washed in TBS pH 7.6.
Detection of latent EBV infection
In situ hybridization for the detection of the EBERs was
performed according to standard methodology (Barletta et al,
1993) and was used to detect the presence of latent EBV infection
in all HD samples. Positive controls for EBER in situ hybridiza-
tion included paraffin-wax sections of lymphoblastoid cell lines
(LCLs) grown as solid tumours in SCID mice and a known EBER-
positive HD case. U6 and sense control probes were included in all
runs and their use has been previously described elsewhere
(Barletta et al, 1993). Immunohistochemistry for LMP1 was
performed on selected cases to confirm the presence of EBV infec-
tion in HRS cells. The standard APAAP method was employed
and sections were microwave pre-treated as previously described
(Murray et al, 1996a). Positive controls for LMP1 consisted of
paraffin-wax sections of LCLs grown as solid tumours in SCID
mice. Negative controls consisted of consecutive test sections in
which primary antibody was replaced with non-immune serum of
the same IgG subclass.
Determination of material deprivation
Townsend scores matched to enumeration district and based on
data from the 1991 OPCS census were generated from postcodes
available for each patient. The Townsend score has been widely
accepted as an indicator of material deprivation (Morris and
Carstairs, 1991) and is calculated using statistical methods from
the following four variables (Townsend et al, 1988; Bithell et al,
1995):
1. Percent of economically active residents (aged 16–64 for men,
16–59 for women) who are unemployed.
2. Percent of households without a car.
3. Percent of households not owner occupied.
4. Percent of households overcrowded (more than one person per
room).
Statistical methods
Tumour specimens were recorded as either EBV-positive (EBERs
and LMP1 present within HRS cells) or EBV-negative (EBERs
and LMP1 not detectable in HRS cells). EBV status was then
compared with Townsend scores for all patients, and for several
subgroups of patients based on gender, age and subtype.
Mann–Whitney and c2 tests and logistic regression methods were
used to identify any significant differences between EBV-positive
and negative groups in terms of Townsend score.
RESULTS
Detection of latent EBV infection in HD samples
The presence of latent EBV infection, as detected by in situ
hybridization for the EBERs, was identified in HRS cells in
47/223 (21%) cases (EBV-positive group). The remaining 176
(79%) cases did not show the presence of the EBERs within HRS
Table 1 Townsend scores for Hodgkin’s disease patients, by subtype, age and gender
EBV-positive EBV-negative
Mann–Whitney
No. of 25th 75th 25th 75th test
patients n (%) Centile Median Centile n Centile Median Centile P-Value
All patients 223 47 (21) –1.4 2.2 4.0 176 –2.4 1.3 3.3 0.12
All patients except LP and 172 39 (23) –1.7 2.2 3.9 133 –2.1 1.3 3.3 0.26
unknown subtypes
All patients except LP & LD 159 35 (22) –0.5 2.2 4.0 124 –2.4 1.3 3.1 0.06
and unknown subtypes
NS subtype only 118 18 (15) 0.6 2.4 4.0 100 –2.0 1.5 3.3 0.22
MC subtype only 41 17 (41) –1.5 2.2 4.0 24 –3.9 –0.5 2.8 0.09
All male patients 139 37 (27) –1.9 2.0 3.9 102 –1.8 1.1 3.7 0.62
All female patients 84 10 (12) 1.8 3.2 5.2 74 –3.1 1.3 3.1 0.03
All patients 0–14 years 7 0 (0) – – – 7 – –1.9 – –
All patients 15–34 years 99 21 (21) –1.3 2.2 4.0 78 –2.8 1.2 3.1 0.18
All patients 35–54 years 40 9 (23) – 0.9 – 31 –2.7 1.8 4.0 0.34
All patients >55 years 77 17 (22) –0.5 2.7 4.8 60 –1.2 1.1 3.8 0.14
LP: lymphocyte predominant, LD: lymphocyte depletion, NS: nodular sclerosis, MC: mixed cellularity.cells and will subsequently be referred to as the EBV-negative
group. Immunohistochemistry for the LMP1 protein gave similar
results to EBER in situ hybridization.
Socioeconomic deprivation and EBV positivity
Townsend values ranged from –6.6 to +7.8. The majority of
EBV-positive patients (33/47) had Townsend scores above zero
(indicating higher levels of material deprivation), whereas rela-
tively fewer (101/176) EBV-negative patients had scores above
zero (c2 test, P = 0.11, i.e. not significant). Median Townsend
scores for EBV-positive and EBV-negative groups were 2.2 and
1.3 respectively. The Mann–Whitney test gave a P-value of 0.12
(Table 1), also not significant.
Similar results were obtained when patients of unknown
subtype together with those with lymphocyte predominant (LP)
subtype were removed from the analysis (P = 0.26) When the
lymphocyte depletion (LD) subtype was also removed from the
analysis, the Mann–Whitney test gave a P-value of 0.06 (i.e. of
borderline significance).
The nodular sclerosis (NS) and mixed cellularity (MC) subtypes
were also analysed separately. As expected, fewer NS cases were
EBV-positive (18/118) when compared to MC patients (17/41). In
both subtypes the trend towards higher Townsend scores for EBV-
positive patients was maintained, particularly for MC patients
(P = 0.09). However, the differences were not of statistical signifi-
cance in either subtype.
Differences in the level of material deprivation between EBV-
positive and EBV-negative groups were also influenced by gender.
Overall, male patients were more numerous in this study (139
male vs 84 female) and were more likely to be EBV-positive than
female patients (37/139 = 27% male patients, and 10/84 = 12%
female patients, were EBV-positive; P < 0.05). Although there was
a tendency for higher Townsend scores in both male and female
EBV-positive patients when compared to EBV-negative groups,
this relationship was weaker for males (P = 0.62), but achieved
statistical significance for females (P = 0.03). Further analysis of
the female data revealed that the EBV-positive tumours were
generally from older patients (median age 67 years), when
compared to EBV-negative patients (median age 34 years) and
were more likely to be of mixed cellularity subtype (50% of EBV-
positive patients compared to only 10% for EBV-negative cases).
We were also interested to identify any differences in the groups
in terms of age. EBV-positive and -negative patients were sub-
divided into age ranges: 0–14, 15–34, 35–54, > 55 years.
Statistical analysis of the youngest age group was not valid due to
low numbers. In none of the other age groups was there a statisti-
cally significant difference in Townsend scores between the
EBV-positive and EBV-negative patients.
A stepwise logistic regression analysis was also performed with
EBV status as the outcome or dependent variable. The predictor
variables used were age (0–14, 15–34, 35–54, > 55 years), subtype
(MC, NS, LP/LD), gender and Townsend scores. Patients with
Hodgkin’s disease of unknown subtype were excluded from this
analysis. Subtype was the strongest predictor of EBV-positive
status (P = 0.0023). Gender then added to the prediction at the 5%
level (P = 0.03). At no stage did age-group appear to be an influ-
ential predictor, while Townsend values were of borderline signif-
icance as a predictor at the outset of the regression (P = 0.15)
and also after subtype group and gender had been allowed for
(P = 0.11).
When the logistic regression was re-run, excluding LP and LD
subtypes, the main predictor of EBV-positive status was again
subtype (P < 0.001), but with Townsend score in second place
(P = 0.03). After subtype had been allowed for, gender no longer
appeared an influential predictor (P = 0.18).
DISCUSSION
Among persons under the age of 45, the age-incidence curve of
Hodgkin’s disease varies according to the level of socioeconomic
development (MacMahon, 1966; Correa and O’Conor, 1971). In
developed populations, the incidence of HD is low among
children, increases sharply through adolescence, peaks at around 30
years, and then declines until the mid-40s (Gutensohn and Cole,
1981; Bernard et al, 1987). By contrast, in underdeveloped countries
there is an early incidence peak in childhood that affects predomi-
nantly boys, and only a modest increase through adolescence. Taken
together these patterns suggest that material deprivation in child-
hood is associated with a greater risk of paediatric HD, while HD in
young adults is associated more with relative affluence. At older
ages HD is the result of a decline in immune function, and this in
turn may be related to deprivation. It has been suggested that HD
may be a rare consequence of infection with a common virus, and
that the probability of its occurrence increases when infection is
delayed until adolescence or young adulthood (Shimkin, 1955).
Our results have demonstrated a tendency for higher Townsend
scores in EBV-positive HD patients compared with EBV-negative
cases, indicating that EBV-positive HD in the UK is more likely in
patients from materially deprived areas. This relationship was
strongest when the lymphocyte predominant and lymphocyte deple-
tion subtypes were excluded from the analyses. Lymphocyte-
predominant disease differs morphologically, immunophenotypically
and clinically from classic HD (Linden et al, 1988; Harris et al, 1994;
Stoler et al, 1995) and there is controversy over the morphological
distinction between LD HD and anaplastic large cell lymphoma in
which EBV is also implicated as a pathogen (Herbst et al, 1991; Stein
et al, 1991; Frizzera, 1992; Hansmann and Kuppers, 1996).
The higher frequency of EBV-positive cases and the Townsend
scores among the latter for the mixed cellularity subtypes of HD
accords with results from underdeveloped populations in which MC
HD has previously been reported to be proportionally more common
and is frequently EBV-positive (Ambinder et al, 1993; Chang et al,
1993; Leoncini et al, 1996; Weinreb et al, 1996a, 1996b). Thus, our
results suggest that, within this subtype, socioeconomic factors may
be particularly important in determining EBV positivity.
When gender was examined, female patients with EBV-positive
disease tended to have higher Townsend scores than the EBV-
negative group (P = 0.03). The pattern of occurrence was similar
for male patients, but the difference was not statistically signifi-
cant. This study also shows that males overall are more likely to
develop EBV-positive HD than females (P = 0.02), confirming
previous studies from the UK (Murray et al, 1996b). Gender
differences are also apparent when comparing developed and
developing populations. Males, particularly boys with EBV-posi-
tive MC disease, tend to characterize HD in underdeveloped popu-
lations, whereas young adult females with EBV-negative NS
disease are primarily responsible for the young adult peak
observed in developed countries (Ambinder et al, 1993; Gulley et
al, 1994; Jarrett et al, 1996; Glaser et al, 1997). It has been
suggested that these differences may be due to variations in the
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childhood social environment, between boys and girls (Gutensohn
and Cole, 1981). We can speculate that, for boys, risk factors for
EBV-positive HD are often present, irrespective of the level of
material deprivation, whereas for girls, they are only present under
impoverished conditions. Thus, we might expect only minor
effects of material deprivation on the frequency of EBV-positivity
in males, but a much more dramatic effect in females.
When patients were grouped into the commonly accepted age
ranges we were unable to find any significant differences in
Townsend scores between EBV-positive and -negative groups
although at ages 15–34 and > 55 (for which the numbers were
largest) the pattern of occurrence for Townsend score by EBV
status was similar to that for the total study group. Clearly, there is
a need to examine further the possible impact of Townsend scores
on EBV positivity within various age groups. Ethnic or racial
differences have also been shown to affect the frequency of EBV
positivity in HD. In one study, three of four Hispanic Americans,
but only one of five blacks and four of ten Caucasians were EBV-
positive (Ambinder et al, 1993). Analysis of a much larger series
of HD cases by Gulley et al (1994) also showed an association
with Hispanic ethnicity (P < 0.001). Several UK studies have
shown that Asian children have a higher rate of HD, with an esti-
mated relative risk of 2.09 (Stiller et al, 1991; Muir et al, 1992;
Varghese et al, 1996), but data on the frequency of EBV positivity
in these tumours is not available. We were not able to determine
ethnic or racial origin in our group of patients and the possibility
that these factors may confound any association between EBV
positivity in HD and material deprivation cannot be ruled out.
Clearly, further analysis taking into account ethnic or racial differ-
ences is required. We have used computer-derived Townsend
scores, matched for enumeration districts identified from post-
codes as a measure of material deprivation for each patient.
Studies of ‘small areas’ have been recognized as an acceptable
basis for investigating the influence of material deprivation on
different aspects of health (Carstairs, 1981a; Townsend et al,
1988). In particular, studies using enumeration districts, rather than
wards or other larger areas (Carstairs, 1981b), are considered more
reliable since they tend to have more socially homogenous popula-
tions and their small size allows greater geographical resolution
(Reading and Openshaw, 1993). There are, however, some
acknowledged sources of inaccuracy in this approach. These
include social heterogeneity within enumeration districts (Carr-
Hill and Sheldon, 1991), in which the average Townsend score
may be unrepresentative of some individuals within the district,
and the possibility of social change, either before or after a census
(Carr-Hill and Sheldon, 1991). There has also been some contro-
versy over whether the census-derived deprivation scores actually
measure an area’s experience of material deprivation (Morris and
Carstairs, 1991). We consider that despite their limitations for cate-
gorizing individual patients or areas, the Townsend scores have
proven value for indicating average experience. Nonetheless, we
could obtain information on material deprivation for patients only
at the time of diagnosis. It may, of course, be that the frequency of
EBV positivity in HD is affected by socioeconomic factors that are
not necessarily present at the time of diagnosis, but which were
extant some time prior to this, possibly during childhood.
CONCLUSION
Our study has indicated that socioeconomic factors that seemingly
account for differences in the relative proportions of EBV-positive
and EBV-negative HD between countries, also appear to play a
role in determining the frequency of EBV positivity within the
UK. It is not known whether socioeconomic conditions affect the
rate or timing of primary EBV infection, which may ultimately
influence the likelihood of EBV positivity in HD. Alternatively,
material deprivation may contribute to a decline in EBV-specific
immunity, which may in turn also favour the development of EBV-
positive HD.
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